A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax PLoS Medicine, 07 Dec 2022 by Yang Yang, Yamin Shu, Guosong Chen, Yanchao Yin, Feie Li, Juan Li Background Venetoclax (VEN) is the first selective small…